Effects of irisin on osteoblast apoptosis and osteoporosis in postmenopausal osteoporosis rats through upregulating Nrf2 and inhibiting NLRP3 inflammasome

Xu,Lili; Shen,Liyan; Yu,Xiaolong; Li,Peng; Wang,Qing; Li,Chengqian

doi:10.3892/etm.2019.8313

Effects of irisin on osteoblast apoptosis and osteoporosis in postmenopausal osteoporosis rats through upregulating Nrf2 and inhibiting NLRP3 inflammasome

Authors:
- Lili Xu
- Liyan Shen
- Xiaolong Yu
- Peng Li
- Qing Wang
- Chengqian Li
View Affiliations

Affiliations: Department of Endocrinology and Metabolism, The Affiliated Hospital of Qingdao University, Qingdao, Shandong 266000, P.R. China
Published online on: December 10, 2019 https://doi.org/10.3892/etm.2019.8313
Pages: 1084-1090
Copyright: © Xu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The nuclear factor E2‑related factor 2 (Nrf2)/NLR family, pyrin domain containing protein 3 (NLRP3) plays an important role in osteoporosis (OP), so the effects of irisin on postmenopausal OP rats and osteoblast apoptosis through Nrf2/NLRP3 were explored in the present study. A total of 45 specific pathogen‑free Sprague‑Dawley rats were selected and divided into OP model group (OP group, n=15), 1 mmol/l irisin treatment group (irisin group, n=15) and normal control group (control group, n=15). After the trial period, the content of serum ALP was detected, the levels of tumor necrosis factor‑α (TNF‑α) in the serum and bone tissues were observed via ELISA, and the bone microstructure was observed via CT. Osteoblast apoptosis was determined through TUNEL assay, the content of apoptosis genes caspase‑3 and Bcl‑2, and key genes in Runt‑related transcription factor 2 (Runx2), osteocalcin (OC), Nrf2 and NLRP3 was detected via RT‑PCR. The protein expression of Bcl‑2, Nrf2 and NLRP3 was determined via western blotting. The serum ALP level was increased in OP group compared with that in control group (P<0.05), while it declined in the irisin group. The content of TNF‑α and interleukin-6 (IL‑6) was significantly higher in OP group, while the content in the irisin group was close to that in the control group. The trabecular thickness, number and bone mineral density in the irisin group were all obviously larger and higher, respectively, than those in the OP group. The mRNA expression of Runx2, OC, Bcl‑2 and Nrf2 in the irisin group were obviously higher (P<0.05), while that of caspase‑3 and NLRP3 showed the opposite trends. The protein expression of Bcl‑2 and Nrf2 in the irisin group was remarkably higher than those in the OP group, while that of NLRP3 was the opposite. irisin can upregulate Nrf2, inhibit NLRP3 inflammasome and lower the content of inflammatory factors, thereby suppressing osteoblast apoptosis in postmenopausal OP rats and reducing the incidence of postmenopausal OP.

View Figures

View References

1	Zhang J, Lazarenko OP, Blackburn ML, Shankar K, Badger TM, Ronis MJ and Chen JR: Feeding blueberry diets in early life prevent senescence of osteoblasts and bone loss in ovariectomized adult female rats. PLoS One. 6:e244862011. View Article : Google Scholar : PubMed/NCBI
2	Zhao X, Wu ZX, Zhang Y, Gao MX, Yan YB, Cao PC, Zang Y and Lei W: Locally administered perindopril improves healing in an ovariectomized rat tibial osteotomy model. PLoS One. 7:e332282012. View Article : Google Scholar : PubMed/NCBI
3	Cano A, Chedraui P, Goulis DG, Lopes P, Mishra G, Mueck A, Senturk LM, Simoncini T, Stevenson JC, Stute P, et al: Calcium in the prevention of postmenopausal osteoporosis: EMAS clinical guide. Maturitas. 107:7–12. 2018. View Article : Google Scholar : PubMed/NCBI
4	Kikuta J and Ishii M: Bone imaging: Osteoclast and osteoblast dynamics. Methods Mol Biol. 1763:1–9. 2018. View Article : Google Scholar : PubMed/NCBI
5	Yu-Lee LY, Yu G, Lee YC, Lin SC, Pan J, Pan T, Yu KJ, Liu B, Creighton CJ, Rodriguez-Canales J, et al: Osteoblast-secreted factors mediate dormancy of metastatic prostate cancer in the bone via activation of the TGFβRIII-p38MAPK-pS249/T252RB pathway. Cancer Res. 78:2911–2924. 2018. View Article : Google Scholar : PubMed/NCBI
6	Matsuo K: Cross-talk among bone cells. Curr Opin Nephrol Hypertens. 18:292–297. 2009. View Article : Google Scholar : PubMed/NCBI
7	Lee WC, Guntur AR, Long F and Rosen CJ: Energy metabolism of the osteoblast: Implications for osteoporosis. Endocr Rev. 38:255–266. 2017. View Article : Google Scholar : PubMed/NCBI
8	Black DM and Rosen CJ: Clinical practice. Postmenopausal osteoporosis. N Engl J Med. 374:254–262. 2016. View Article : Google Scholar : PubMed/NCBI
9	Cheung WH, Miclau T, Chow SK, Yang FF and Alt V: Fracture healing in osteoporotic bone. Injury. 47 (Suppl 2):S21–S26. 2016. View Article : Google Scholar : PubMed/NCBI
10	Sanchez C, Mazzucchelli G, Lambert C, Comblain F, DePauw E and Henrotin Y: Comparison of secretome from osteoblasts derived from sclerotic versus non-sclerotic subchondral bone in OA: A pilot study. PLoS One. 13:e01945912018. View Article : Google Scholar : PubMed/NCBI
11	Hara Y, Ghazizadeh M, Shimizu H, Matsumoto H, Saito N, Yagi T, Mashiko K, Mashiko K, Kawai M and Yokota H: Delayed expression of circulating TGF-β1 and BMP-2 levels in human nonunion long bone fracture healing. J Nippon Med Sch. 84:12–18. 2017. View Article : Google Scholar : PubMed/NCBI
12	Folwarczna J, Zych M and Trzeciak HI: Effects of curcumin on the skeletal system in rats. Pharmacol Rep. 62:900–909. 2010. View Article : Google Scholar : PubMed/NCBI
13	Uemura H, Yasui T, Miyatani Y, Yamada M, Hiyoshi M, Arisawa K and Irahara M: Circulating profiles of osteoprotegerin and soluble receptor activator of nuclear factor kappaB ligand in post-menopausal women. J Endocrinol Invest. 31:163–168. 2008. View Article : Google Scholar : PubMed/NCBI
14	Ibáñez L, Ferrándiz ML, Brines R, Guede D, Cuadrado A and Alcaraz MJ: Effects of Nrf2 deficiency on bone microarchitecture in an experimental model of osteoporosis. Oxid Med Cell Longev. 2014:7265902014. View Article : Google Scholar : PubMed/NCBI
15	Park CK, Lee Y, Kim KH, Lee ZH, Joo M and Kim HH: Nrf2 is a novel regulator of bone acquisition. Bone. 63:36–46. 2014. View Article : Google Scholar : PubMed/NCBI
16	Zhu H, Zhang L, Itoh K, Yamamoto M, Ross D, Trush MA, Zweier JL and Li Y: Nrf2 controls bone marrow stromal cell susceptibility to oxidative and electrophilic stress. Free Radic Biol Med. 41:132–143. 2006. View Article : Google Scholar : PubMed/NCBI
17	Maicas N, Ferrándiz ML, Brines R, Ibáñez L, Cuadrado A, Koenders MI, van den Berg WB and Alcaraz MJ: Deficiency of Nrf2 accelerates the effector phase of arthritis and aggravates joint disease. Antioxid Redox Signal. 15:889–901. 2011. View Article : Google Scholar : PubMed/NCBI
18	Aw Yeang HX, Hamdam JM, Al-Huseini LM, Sethu S, Djouhri L, Walsh J, Kitteringham N, Park BK, Goldring CE and Sathish JG: Loss of transcription factor nuclear factor-erythroid 2 (NF-E2) p45-related factor-2 (Nrf2) leads to dysregulation of immune functions, redox homeostasis, and intracellular signaling in dendritic cells. J Biol Chem. 287:10556–10564. 2012. View Article : Google Scholar : PubMed/NCBI
19	Lee P, Linderman JD, Smith S, Brychta RJ, Wang J, Idelson C, Perron RM, Werner CD, Phan GQ, Kammula US, et al: Irisin and FGF21 are cold-induced endocrine activators of brown fat function in humans. Cell Metab. 19:302–309. 2014. View Article : Google Scholar : PubMed/NCBI
20	Lee MJ, Lee SA, Nam BY, Park S, Lee SH, Ryu HJ, Kwon YE, Kim YL, Park KS, Oh HJ, et al: Irisin, a novel myokine is an independent predictor for sarcopenia and carotid atherosclerosis in dialysis patients. Atherosclerosis. 242:476–482. 2015. View Article : Google Scholar : PubMed/NCBI
21	Palermo A, Strollo R, Maddaloni E, Tuccinardi D, D'Onofrio L, Briganti SI, Defeudis G, De Pascalis M, Lazzaro MC, Colleluori G, et al: Irisin is associated with osteoporotic fractures independently of bone mineral density, body composition or daily physical activity. Clin Endocrinol (Oxf). 82:615–619. 2015. View Article : Google Scholar : PubMed/NCBI
22	Velders M and Diel P: How sex hormones promote skeletal muscle regeneration. Sports Med. 43:1089–1100. 2013. View Article : Google Scholar : PubMed/NCBI
23	Bednarek-Tupikowska G, Tupikowski K, Bidzińska B, Bohdanowicz-Pawlak A, Antonowicz-Juchniewicz J, Kosowska B and Milewicz A: Serum lipid peroxides and total antioxidant status in postmenopausal women on hormone replacement therapy. Gynecol Endocrinol. 19:57–63. 2004. View Article : Google Scholar : PubMed/NCBI
24	Tu KN, Lie JD, Wan CKV, Cameron M, Austel AG, Nguyen JK, Van K and Hyun D: Osteoporosis: A review of treatment options. PT. 43:92–104. 2018.
25	Zhang L, Yin X, Wang J, Xu D, Wang Y, Yang J, Tao Y, Zhang S, Feng X and Yan C: Associations between VDR gene polymorphisms and osteoporosis risk and bone mineral density in postmenopausal women: A systematic review and meta-analysis. Sci Rep. 8:981–989. 2018. View Article : Google Scholar : PubMed/NCBI
26	Saei-Dehkordi SS, Tajik H, Moradi M and Khalighi-Sigaroodi F: Chemical composition of essential oils in Zataria multiflora Boiss. from different parts of Iran and their radical scavenging and antimicrobial activity. Food Chem Toxicol. 48:1562–1567. 2010. View Article : Google Scholar : PubMed/NCBI
27	Yamaza T, Miura Y, Bi Y, Liu Y, Akiyama K, Sonoyama W, Patel V, Gutkind S, Young M, Gronthos S, et al: Pharmacologic stem cell based intervention as a new approach to osteoporosis treatment in rodents. PLoS One. 3:e26152008. View Article : Google Scholar : PubMed/NCBI
28	Yang C, Zeng YP and Yang T: Irisin in restraining IL-1, IL-6, TNF-α and M-CSF expression and its effect in preventing post-menopause osteoporosis. China Pharmaceuticals. 24:15–17. 2015.
29	Klionsky DJ: Autophagy: From phenomenology to molecular understanding in less than a decade. Nat Rev Mol Cell Biol. 8:931–937. 2007. View Article : Google Scholar : PubMed/NCBI
30	Thirunavukkarasu K, Halladay DL, Miles RR, Yang X, Galvin RJ, Chandrasekhar S, Martin TJ and Onyia JE: The osteoblast-specific transcription factor Cbfa1 contributes to the expression of osteoprotegerin, a potent inhibitor of osteoclast differentiation and function. J Biol Chem. 275:25163–25172. 2000. View Article : Google Scholar : PubMed/NCBI
31	Xu H, Wu F, Zhang H, Yang C, Li K, Wang H, Yang H, Liu Y, Ding B, Tan Y, et al: Actin cytoskeleton mediates BMP2-Smad signaling via calponin 1 in preosteoblast under simulated microgravity. Biochimie. 138:184–193. 2017. View Article : Google Scholar : PubMed/NCBI
32	Kanzaki H, Shinohara F, Kajiya M and Kodama T: The Keap1/Nrf2 protein axis plays a role in osteoclast differentiation by regulating intracellular reactive oxygen species signaling. J Biol Chem. 288:23009–23020. 2013. View Article : Google Scholar : PubMed/NCBI
33	Pellegrini GG, Morales CC, Wallace TC, Plotkin LI and Bellido T: Avenanthramides prevent osteoblast and osteocyte apoptosis and induce osteoclast apoptosis in vitro in an Nrf2-independent manner. Nutrients. 8:423–436. 2016. View Article : Google Scholar
34	Ibáñez L, Ferrándiz ML, Brines R, Guede D, Cuadrado A and Alcaraz MJ: Effects of Nrf2 deficiency on bone microarchitecture in an experimental model of osteoporosis. Oxid Med Cell Longev. 2014:7265902014. View Article : Google Scholar : PubMed/NCBI